Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

13.75p
   
  • Change Today:
      0.25p
  • 52 Week High: 33.50
  • 52 Week Low: 9.55
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 228,673
  • Market Cap: £56.72m

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -720.0% -158.8%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 13.9 2.3
Pr/Book 1.3  
Latest F'cast
Revenue n/a 51.4%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CREO Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 9.43 (23.46) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 27.20 (30.90) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-23 4.00 (26.40) (8.00)p n/a n/a n/a n/a 0.0%
31-Dec-24 4.00 (29.00) (8.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CREO Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 6.06 (9.61) (2.07)p n/a n/a n/a n/a 0.0%
31-Dec-26 10.16 (13.45) (2.18)p n/a n/a n/a n/a 0.0%
31-Dec-27 17.67 (7.33) (1.26)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

CREO Company Announcements

Result of AGM 26-Jun-2025 11:08 RNS
AGM Statement and Directorate Changes 26-Jun-2025 07:00 RNS
Director/PDMR Shareholding 02-Jun-2025 07:00 RNS

Latest CREO Director Deals

Traded Action Notifier PriceAmountValue
30-May-25 Buy Kevin Crofton 15.75p 701,750 £110,525.62

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CREO Market Data

Currency UK Pounds
Share Price 13.75p
Change Today 0.25p
% Change 1.85 %
52 Week High 33.50
52 Week Low 9.55
Volume 228,673
Shares Issued 412.47m
Market Cap £56.72m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.92% above the market average5.92% above the market average5.92% above the market average5.92% above the market average5.92% above the market average
3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average
Price Trend
83.26% below the market average83.26% below the market average83.26% below the market average83.26% below the market average83.26% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Income Not Available
Growth
46.9% below the market average46.9% below the market average46.9% below the market average46.9% below the market average46.9% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 26-Jun-2025

Time Volume / Share Price
12:22 888 @ 13.57p
16:06 5,136 @ 13.64p
15:54 1,018 @ 13.51p
14:56 214 @ 13.99p
14:42 714 @ 13.99p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page